Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer.

ABSTRACT:

Background

NICE guidance on the investigation and treatment of ovarian cancer advocates that the tumour marker CA125 should be the first line investigation for women suspected of having ovarian cancer.

Methods

An internet-based survey, of primary care doctors in the West Midlands, was conducted in order to ascertain the views of general practitioners (GPs) of NICE guidance on the use of CA125 to triage suspected ovarian cancer cancers and the impact that this may have on referral pathways.

Results

In total 258 GPs responded to the questionnaire. Although 219 (84.9%) responders reported awareness of the NICE guidance only 146 (56.6%) had personally read the document. The majority 187 (72.5%) of respondents anticipated that their use of CA125 would increase as a result

SUBMITTER: Moss EL 

PROVIDER: S-EPMC3644283 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature